Control of herpes symptoms does not reduce HIV transmission, international study found

January 25, 2010

Research from a five-year international clinical study shows that acyclovir, a commonly prescribed drug used to suppress symptoms of the herpes virus, does not affect HIV transmission by people with both viruses.

The study, conducted by the Partners in Prevention HSV/ Study, was released by the in its online edition Jan. 20 and will follow in the print edition Feb. 4.

The largest risk group worldwide, but particularly in Africa and Asia, for contracting HIV is stable, heterosexual couples where only one partner is infected. Among those infected, about 90 percent also have a herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, said study co-author Kenneth H. Fife, M.D., Ph.D., professor of medicine in the Division of Infectious Diseases at the Indiana University School of Medicine.

"Logic indicated that outbreaks of HSV-2 sores could enhance the transmission of HIV," said Dr. Fife. "This is the first comprehensive study to look at the potential for reducing the transmission of HIV through treatment of the ."

Multiple studies have shown that frequent genital herpes recurrences increase the amount of HIV in the blood and genital tract. It is known that HIV virus is shed through ulcers and people with those ulcers transmit HIV to other more efficiently.

Five preliminary studies showed that it is possible to decrease the amount of HIV in the blood and genital tract through treatment to suppress HSV-2. However, those studies did not measure whether there also was a reduction in HIV transmission.

The study found that acyclovir reduced the occurrence of HSV-2 genital ulcers by 73 percent and thus the amount of HIV present in the blood and decreased twofold.

In spite of the reduction of HIV present in blood levels, the researchers found there was no significant difference in the transmission of . Laboratory testing showed there were 41 infections in the group taking acyclovir and 43 in the placebo group.

Explore further: Herpes on the rise in Australia

Related Stories

Herpes on the rise in Australia

May 19, 2006

One in eight Australian adults has been infected with the virus causing genital herpes, with the rate one in five for women aged 35-44, a study said.

Herpes drug inhibits HIV replication, but with a price

November 6, 2008

The anti-herpes drug acyclovir can also directly slow down HIV infection by targeting the reverse transcriptase (RT) enzyme, researchers report in this week's JBC. This beneficial effect does pose a risk though, as HIV-infected ...

Herpes medication does not reduce risk of HIV transmission

May 8, 2009

A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital ...

Herpes medication does not reduce risk of HIV transmission

January 20, 2010

A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Machine Translates Thoughts into Speech in Real Time

December 21, 2009

(PhysOrg.com) -- By implanting an electrode into the brain of a person with locked-in syndrome, scientists have demonstrated how to wirelessly transmit neural signals to a speech synthesizer. The "thought-to-speech" process ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.